Drug Database
Back to search

Netherlands· NL-29ef799440e2

Apixaban Reddy 5 mg filmomhulde tabletten

A apixaban product containing apixaban, registered in Netherlands by Reddy Holding GmbH. The same ATC class is registered in 17 of our 19 countries.

ATC B01AF02

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedApixaban Reddy 5 mg filmomhulde table…ATCB01AF02REGISTER NO.NL-29ef799440e2PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about apixabanAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Apixaban is registered in 17 of 19 countries.

Countries holding a registration under ATC B01AF02 (apixaban), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 10 of them publish a price we can compare per daily dose
Search apixaban products by name

Apixaban · ATC B01AF02

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of apixaban costs, country by country.

Normalised to the WHO defined daily dose (10 mg), the median price runs from $3.38 in France to $7.97 in Italy — a ×2.4 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Apixaban · price per daily dose (10 mg)

USD · FX 28 Sept 2026

  • IT Italy$7.97
  • CH Switzerland$4.70
  • FR France$3.38
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
APIXABAN
Manufacturer
Reddy Holding GmbH
Country
Netherlands (NL)
ATC code
B01AF02
ATC class
Apixaban
Defined daily dose
10 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    131369

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

398 interactions on record for apixaban.

Graded by severity as the source publishes them — 133 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check apixaban against other medicinesHow interaction checks work

Apixaban · interactions on record

398 records

  • 133 severe
  • 224 moderate
  • 2 minor

Most severe, free to view

  • LonafarnibA16AX20severe
  • DicoumarolB01AA01severe
  • WarfarinB01AA03severe
  • HeparinB01AB01severe

39 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under B01AF02

Apixaban, as other registers publish it.

All apixaban products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b310f5b5-46ef-4caa-b907-54501298a7b1
GET /v1/drugs/b310f5b5-46ef-4caa-b907-54501298a7b1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h131369_smpc.pdf",
  "strength": null,
  "atc_label": "Apixaban",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg131369",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "GLYCEROLTRIACETAAT (E 1518)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "IJZEROXIDE ROOD  (E 172)",
    "LACTOSE 0-WATER",
    "LACTOSE 1-WATER",
    "MAGNESIUMSTEARAAT (E 470b)",
    "NATRIUMLAURILSULFAAT",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "APIXABAN"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h131369.pdf",
  "authorised_at": "2024/08/26",
  "procedure_number": "SE/H/2415/002",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "131369",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about apixaban.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console